Tenon Medical Reports Third Quarter 2023 Financial Results bignewsnetwork.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bignewsnetwork.com Daily Mail and Mail on Sunday newspapers.
Cybin Inc. , a clinical-stage biopharmaceutical company committed to revolutionizing mental healthcare by developing new and innovative next-generation psychedelic treatment options, is pleased to.
Clinical-stage psychedelics biotech Cybin Inc. (NYSE: CYBN) has announced a new underwritten offering of 66.66 million units to one of its largest institutional shareholders as well as new institutional investors.
Revenue of $2.6 Million, up 50% Sequentially from Q2
Commercial Revenue up 62% Year-Over-Year
Total Bookings of $2.9 Million
$53.3 Million Cash Balance – Highest in Company’s History
.